美国食品药品监督管理局批准了第一个分支支架移植,用于复杂的大动脉状症. FDA approves first branched stent graft for complex aortic arch conditions.

美国FDA已经批准NEXUS大动脉系统, 这是首个用于复杂的大动脉弧状疾病的分支支架移植. The U.S. FDA has approved the NEXUS Aortic Arch System, the first branched stent graft for complex aortic arch conditions. 这种微创手术为开放性外科手術提供了更安全的替代方案. This minimally invasive device offers a safer alternative to open surgery. 经过成功的试验数据显示高生存率和低并发症率,批准该药物. The approval follows successful trial data showing high survival and low complication rates.